Status | Study |
Completed |
Study Name: QUILT-2.013: A Trial of AMG 479 or AMG 102 in Combination With Platinum-based Chemotherapy as First-Line Treatment for Extensive Stage Small Cell Lung Cancer Condition: Lung Cancer Small Cell Lung Cancer Solid Tumors Date: 2008-10-23 Interventions: Drug: AMG 479 AMG 479 is admin |
Completed |
Study Name: Evaluation of Different Strategies of Pericardial Drainage After Aortic Valvular Surgery Condition: Pericardial Effusion Late Cardiac Tamponade Date: 2008-05-21 Interventions: Device: Blake Drains (Blake drain, Ethicon USA) |
Completed |
Study Name: Single Agent Alimta in Poor Performance Status in Non-small Cell Lung Cancer Condition: Lung Cancer Date: 2007-07-26 Interventions: Drug: Alimta 500 mg/m^2 by vein Once Over 10 Minutes Every 3 Weeks |
Completed |
Study Name: Phase I/II Safety Study of IPI-504 in Relapsed/Refractory Stage IIIb, or Stage IV Non-small Cell Lung Cancer (NSCLC) Condition: Lung Cancer Date: 2007-01-31 Interventions: Drug: IPI-504 IV Hsp90 inhibitor |
Completed |
Study Name: Study of NOV-002 in Combination With Chemotherapy to Treat Lung Cancer Condition: Non Small Cell Lung Cancer Date: 2006-06-29 Interventions: Drug: Paclitaxel and Carboplatin |
Completed |
Study Name: Non Steroidal Anti Inflammatory Treatment for Post Operative Pericardial Effusion Condition: Pericardial Effusion Date: 2005-10-28 Interventions: Drug: diclofenac diclofenac 50 |
Completed |
Study Name: Trial of Drainage With or Without Bleomycin Instillation for Malignant Pericardial Effusion Condition: Malignant Pericardial Effusion Date: 2005-08-19 Interventions: Procedure: Observation alone after pericardial drainage |
Active, not recruiting |
Study Name: Erlotinib Hydrochloride With or Without Carboplatin and Paclitaxel in Treating Patients With Stage III-IV Non-small Cell Lung Cancer Condition: Adenosquamous Lung Carcinoma Bronchioloalveolar Carcinoma Date: 2005-08-02 Interventions: Drug: Carboplatin Given IV |
Completed |
Study Name: Trastuzumab Plus R115777 in Treating Patients With Advanced or Metastatic Cancer Condition: Cancer Date: 2000-06-02 Interventions: Biological: trastuzumab Drug: tipifarnib |
Completed |
Study Name: ILX-295501 in Treating Patients With Stage III or Stage IV Ovarian Cancer That Has Not Responded to Previous Treatment Condition: Fallopian Tube Cancer Metastatic Cancer Ovarian Cancer Date: 2000-05-02 Interventions: Drug: ILX-295501 |